Therapeutic options for chronic hepatitis B: Considerations and controversies

American Journal of Gastroenterology

Volumn 101, Issue 1 SUPPL. 1, 2006, Pages

  Jacobson, Ira M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADEFOVIR DIPHOSPHATE; ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ANTIVIRUS AGENT; CREATININE; DRUG METABOLITE; ENTECAVIR; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; PEGINTERFERON ALPHA2A; UNCLASSIFIED DRUG; VIRUS DNA;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; BONE MARROW TOXICITY; CHILL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DEPRESSION; DISEASE EXACERBATION; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; FEVER; FLU LIKE SYNDROME; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IRRITABILITY; KIDNEY INJURY; LIVER CIRRHOSIS; MALAISE; MENTAL DISEASE; MOOD DISORDER; MYALGIA; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VIREMIA;

ADENINE; ANTIVIRAL AGENTS; DECISION MAKING; DNA, VIRAL; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERONS; LAMIVUDINE; PHOSPHONIC ACIDS; PRACTICE GUIDELINES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 33644904048     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00477.x     Document Type: Review

References (45)

1. Wong DKH Cheung AM O'Rourke K et al Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B Ann Intern Med 1993 119 312 23
2. Niederau C Heintges T Lange S et al Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B N Engl J Med 1996 334 1422 7
3. Lin SM Sheen IS Chien RN et al Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 1999 29 971 5
4. Perrillo RP Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations Hepatology 1990 12 1433 5
5. Lok AS Wu PC Lai CL et al A controlled trial of interferon with or without prednisone priming for chronic hepatitis B Gastroenterology 1992 102 2091 7
6. Keeffe EB Dieterich DT Han SHB et al A treatment algorithm for the management of chronic hepatitis B virus infection in the United States Clin Gastroenterol Hepatol 2004 2 87 106
7. Yuen MF Hui CK Cheng CC et al Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications Hepatology 2001 34 139 45
8. Lampertico P Del Ninno E Manzin A et al A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum Hepatology 1997 26 1621 5
9. Olivieri F Santatonio T Bellati G et al Long-term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon Am J Gastroenterol 1999 94 1366 72
10. Brunetto MR Olivieri F Coco B et al Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: A long-term cohort study J Hepatol 2002 36 263 70
11. Manesis EK Hadziyannis SJ Interferon-α treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B Gastroenterology 2001 121 101 9
12. Papatheodoridis GV Manesis E Hadziyannis SJ The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B Hepatology 2001 34 306 13
13. Brook MG Karayiannis P Thomas HC Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors Hepatology 1989 10 761 3
14. Manns MP Current state of interferon therapy in the treatment of chronic hepatitis B Semin Liver Dis 2002 22 suppl 1 7 13
15. Fung SK Lok AS Treatment of chronic hepatitis B: Who to treat, what to use, and for how long? Clin Gastroenterol Hepatol 2004 2 839 48
16. Kao JH Wu NH Chen PJ et al Hepatitis B genotypes and the response to interferon therapy J Hepatol 2000 33 998 1002
17. Kao JH Hepatitis B viral genotypes: Clinical relevance and molecular characteristics J Gastroenterol Hepatol 2002 17 643 50
18. Korenman J Baker B Waggoner J et al Long-term remission of chronic hepatitis B after alpha-interferon therapy Ann Intern Med 1991 114 629 34
19. Lee WM Hepatitis B virus infection N Engl J Med 1997 337 1733 45
20. Perrillo RP Mason AL Therapy for hepatitis B virus infection Gastroenterol Clin North Am 1994 23 581 601
21. Lai CL Chien RN Leung NWY et al A one-year trial of lamivudine for chronic hepatitis B N Engl J Med 1998 339 61 8
22. Dienstag JL Schiff ER Wright TL et al Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 1999 341 1256 63
23. Schalm SW Heathcote J Cianciara J et al Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial Gut 2000 46 562 8
24. Schiff ER Dienstag JL Karayalcin S et al Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders J Hepatol 2003 38 818 26
25. Gauthier J Bourne EJ Lutz MW et al Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine J Infect Dis 1999 180 1757 62
26. Liaw YF Yeung NWY Chang TT et al Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 2000 119 172 80
27. Dienstag JL Cianciara J Karaylcin S et al Durability of serologic response after lamivudine treatment of chronic hepatitis B Hepatology 2003 37 748 55
28. Tassopoulos NC Volpes R Pastore G et al Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B Hepatology 1999 29 889 96
29. Hadziyannis SJ Papatheodoridis GV Dimou E et al Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B Hepatology 2000 32 847 51
30. Lai CL Dienstag J Schiff E et al Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 2003 36 687 96
31. Dienstag JL Goldin RD Heathcote J et al Histological outcome during long-term lamivudine therapy Gastroenterology 2003 124 105 17
32. Liaw YF Sung JJ Chow WC et al Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 2004 351 1521 31
33. Marcellin P Chang TT Lim SG et al Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 2003 348 808 16
34. Hadziyannis SJ Tassopoulos NC Heathcote EJ et al Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 2003 348 800 7
35. Marcellin P Chang TT Lim S et al Long term efficacy and safety of adefovir dipivoxil (ADV) 10 mg in HBeAg+ chronic hepatitis B (CHB) patients: Increasing serologic, virologic and biochemical response over time Hepatology 2004 40 suppl 1 A655
36. Chang TT Shiffman M Tong M et al Durability of HBeAg seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB) J Hepatol 2004 40 suppl 1 424A
37. Hadziyannis S Tassopoulos N Heathcote E et al Long-term (96 weeks) adefovir dipivoxil in HBeAg negative chronic hepatitis results in significant virological, biochemical and histological improvement Hepatology 2003 38 suppl 1 273A
38. Qi X Snow A Thibault V et al Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy J Hepatol 2004 40 suppl 1 A57
39. Hadziyannis S Tassopoulos N Chang TT et al Long-term adefovir treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: Results after 5 years of therapy Hepatology 2005 42 suppl 1 754A
40. Peters MG Hann HW Martin P et al Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B Gastroenterology 2004 126 91 101
41. Lok ASF McMahon BJ American Association for the Study of Liver Diseases Practice Guideline: Chronic hepatitis B Hepatology 2001 34 1225 41
42. Schalm SW Heathcote J Cianciara J et al Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial Gut 2000 46 562 8
43. Sung JJY Lai JY Zeuzem et al A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir (ADV) for treatment naïve patients with chronic hepatitis B (CHB): Week 52 analysis J Hepatol 2003 38 suppl A4313
44. Dienstag JL Looking to the future: New agents for chronic hepatitis B Am J Gastroenterol 2006 101 S19 25
45. Yang LM Xu KC Zhao YL et al Clinical significance of liver biopsy in chronic hepatitis B patients with persistently normal transaminase Chin J Dig Dis 2002 3 150 4